Efficacy and safety of bazedoxifene for postmenopausal osteoporosis.
about
Targeted approaches in the treatment of osteoporosis: differential mechanism of action of denosumab and clinical utility.The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosisBazedoxifene versus oral bisphosphonates for the prevention of nonvertebral fractures in postmenopausal women with osteoporosis at higher risk of fracture: a network meta-analysis.Efflux and uptake transporters involved in the disposition of bazedoxifene.A single nucleotide polymorphism in the TGF-β1 gene (rs1982073 C>T) may contribute to increased risks of bone fracture, osteoporosis, and osteoarthritis: a meta-analysis.
P2860
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis.
@ast
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis.
@en
type
label
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis.
@ast
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis.
@en
prefLabel
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis.
@ast
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis.
@en
P2860
P356
P1476
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis.
@en
P2093
Hisaya Kawate
Ryoichi Takayanagi
P2860
P304
P356
10.2147/CIA.S15711
P407
P577
2011-06-21T00:00:00Z